Skip to content

Effect of Sasa powder intake or/and a 60 Hz electric field treatment on sleep quality.

Effect of Sasa powder intake or/and a 60 Hz electric field treatment on sleep quality. - Effect of Sasa powder intake or/and a 60 Hz electric field treatment on sleep quality.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000035978
Enrollment
3
Registered
2019-02-22
Start date
2019-02-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy humans

Interventions

Oral ingestion of the test food once a day for 4 weeks Electric potential therapy equipment used for 4 weeks during sleep

Sponsors

Miura Clinic, Medical Corporation Kanonkai
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: (1) 40<=Age<64 of healty men and women (2) Subjects in menopause (3) Subjects with reduced sleep quality (4) Subjects not taking drugs such as sleeping pills (5) Subjects who received a sufficient explanation of the purpose and details of the examination, voluntarily participate in voluntary participation after having a good understanding, understanding well and agreeing to participate in the examination in writing

Exclusion criteria

Exclusion criteria: (1) Subjects with diabetes, liver disease, kidney disease, gastrointestinal disease, peripheral vascular disease, or medical history for severe diseases (2) Subjects who are diagnosed with heart disease and are restricted from daily extreme exercise (3) Subjects using implantable medical electrical devices (pacemakers, implantable defibrillators, etc.) that are susceptible to electromagnetic interference (4) Subjects using wearable medical electrical devices (electrocardiographs, pacemakers, etc.) (5) Subjects who indicate abnormal parameter in liver or kidney function (6) Subjects with a disease under treatment now (7) Subjects with drug or food allergy (8) Subjects who play high intensity sports or are on a diet (9) Subjects who can not stop taking health foods (including food for specified health uses, foods with function claimss) or designated quasi drugs during the examination period (10) Subjects taking continuous medication (including OTC, prescription drugs) (11) Subjects taking health foods, quasi-drugs, medicines (including OTC, prescription medicine) expected to improve insomnia (12) Subjects using sleep-promoting bedding / equipment (13) Subjects who have used Healthtron or other electric potential therapy devices at present or in the past (14) Subjects who consume excess alcohol or who can not abstain from the day before the test to the day during the sleep brain wave measurement period (15) Subject who has been pregnant or subject who have a plan to become pregnant or breast feed during the study period (16) Subjects who is participating in the other study or planning to participate during the study period (17) Subjects deemed unsuitable by the investigator for other reasons

Design outcomes

Primary

MeasureTime frame
Brain waves during sleep

Secondary

MeasureTime frame
OSA sleep inventory MA version Visual Analogue Scale

Countries

Japan

Contacts

Public ContactMakoto Terashima

Oneness Support Co., Ltd. Clinical Trial Division

mterashima@oneness-sup.co.jp0648018917

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026